nach oben

Clinical Oral Investigations

Erschienen in:

14.12.2017 | Original Article

Activity of taurolidine gels on ex vivo periodontal biofilm

verfasst von: Luca Pirracchio, Aline Joos, Nina Luder, Anton Sculean, Sigrun Eick

Erschienen in: Clinical Oral Investigations | Ausgabe 5/2018

Einloggen, um Zugang zu erhalten

Abstract

Objectives

The purpose of this study is to evaluate the activity of two different taurolidine (TAU) gels in comparison with a 0.2% chlorhexidine (CHX) gel on an ex vivo subgingival biofilm.

Material and methods

Subgingival including supragingival biofilm samples from periodontitis patients were cultured for 10 days, before TAU 1% and TAU 3% gels and CHX gel were applied for 10 min and thereafter diluted with nutrient media to 10% for 50 min. One third of the samples were analyzed for bacterial counts, biofilm quantity, and biofilm metabolic activity. In the two other thirds, 90% of the nutrient media were replaced and biofilms were incubated for 23 h. The second third was analyzed in the same way as before. In the third part, patients’ microorganisms were added again and incubated for additional 24 h to allow reformation of biofilm before proceeding to analysis.

Results

Decrease of bacterial counts in biofilms was highest following application of TAU 3% after 60 min (0.87 log₁₀ cfu, corresponding 86.5%), 24 and 48 h (reformation of biofilms), respectively. All antimicrobials reduced biofilm quantity after 24 h (each p < 0.05) and following reformation of biofilms (each p < 0.01). Metabolic activity in biofilms was decreased at 60 min (each p < 0.05) and at 24 h (each p < 0.01) after application of TAU gels, while the activity of the reformed biofilm was lower after application of all evaluated antimicrobials (each p < 0.01) than in the control group (e.g., without exposure to antimicrobials).

Conclusion

The antimicrobial activity of taurolidine gels clearly depends on its taurolidine concentration. A high concentrated taurolidine gel is equally active or even superior to 0.2% chlorhexidine gel. However, the activity of antimicrobials is limited in a complex established biofilm and underlines the pivotal role of mechanical biofilm disruption.

Clinical relevance

Within their limits, the data suggest that TAU 3% gel might represent a potential alternative to 0.2% chlorhexidine gel.

Silva N, Abusleme L, Bravo D, Dutzan N, Garcia-Sesnich J, Vernal R, Hernandez M, Gamonal J (2015) Host response mechanisms in periodontal diseases. J Appl Oral Sci 23(3):329–355. https://doi.org/10.1590/1678-775720140259 PubMedPubMedCentralCrossRef

Hajishengallis G (2014) Immunomicrobial pathogenesis of periodontitis: keystones, pathobionts, and host response. Trends Immunol 35(1):3–11. https://doi.org/10.1016/j.it.2013.09.001S1471-4906(13)00145-2 PubMedCrossRef

Lang NP (2015) Group B. Reactor report. Non-surgical periodontal therapy: mechanical debridement, antimicrobial agents and other modalities. J Int Acad Periodontol 17(1 Suppl):31–33PubMed

Herrera D (2016) Scaling and root planning is recommended in the nonsurgical treatment of chronic periodontitis. J Evid Based Dent Pract 16(1):56–58. https://doi.org/10.1016/j.jebdp.2016.01.005 PubMedCrossRef

Leszczynska A, Buczko P, Buczko W, Pietruska M (2011) Periodontal pharmacotherapy—an updated review. Adv Med Sci 56(2):123–131. https://doi.org/10.2478/v10039-011-0044-9 PubMedCrossRef

Baehni PC, Takeuchi Y (2003) Anti-plaque agents in the prevention of biofilm-associated oral diseases. Oral Dis 9(Suppl 1):23–29. https://doi.org/10.1034/j.1601-0825.9.s1.5.x PubMedCrossRef

Cosyn J, Sabzevar MM (2007) Subgingival chlorhexidine varnish administration as an adjunct to same-day full-mouth root planing. II. Microbiological observations. J Periodontol 78(3):438–445. https://doi.org/10.1902/jop.2007.060222 PubMedCrossRef

De Soete M, Mongardini C, Peuwels M, Haffajee A, Socransky S, van Steenberghe D, Quirynen M (2001) One-stage full-mouth disinfection. Long-term microbiological results analyzed by checkerboard DNA-DNA hybridization. J Periodontol 72(3):374–382. https://doi.org/10.1902/jop.2001.72.3.374 PubMedCrossRef

Hidalgo E, Dominguez C (2001) Mechanisms underlying chlorhexidine-induced cytotoxicity. Toxicol in Vitro 15(4-5):271–276. https://doi.org/10.1016/S0887-2333(01)00020-0 PubMedCrossRef

10.

Eick S, Goltz S, Nietzsche S, Jentsch H, Pfister W (2011) Efficacy of chlorhexidine digluconate-containing formulations and other mouthrinses against periodontopathogenic microorganisms. Quintessence Int 42(8):687–700PubMed

11.

Lorenz K, Bruhn G, Heumann C, Netuschil L, Brecx M, Hoffmann T (2006) Effect of two new chlorhexidine mouthrinses on the development of dental plaque, gingivitis, and discolouration. A randomized, investigator-blind, placebo-controlled, 3-week experimental gingivitis study. J Clin Periodontol 33(8):561–567. https://doi.org/10.1111/j.1600-051X.2006.00946.x PubMedCrossRef

12.

Laugisch O, Ramseier CA, Salvi GE, Hagi TT, Burgin W, Eick S, Sculean A (2016) Effects of two different post-surgical protocols including either 0.05% chlorhexidine herbal extract or 0.1% chlorhexidine on post-surgical plaque control, early wound healing and patient acceptance following standard periodontal surgery and implant placement. Clin Oral Investig. https://doi.org/10.1007/s00784-016-1713-7

13.

Zandbergen D, Slot DE, Niederman R, Van der Weijden FA (2016) The concomitant administration of systemic amoxicillin and metronidazole compared to scaling and root planing alone in treating periodontitis: a systematic review. BMC Oral Health 16(1):27. https://doi.org/10.1186/s12903-015-0123-6 PubMedPubMedCentralCrossRef

14.

Harks I, Koch R, Eickholz P, Hoffmann T, Kim TS, Kocher T, Meyle J, Kaner D, Schlagenhauf U, Doering S, Holtfreter B, Gravemeier M, Harmsen D, Ehmke B (2015) Is progression of periodontitis relevantly influenced by systemic antibiotics? A clinical randomized trial. J Clin Periodontol 42(9):832–842. https://doi.org/10.1111/jcpe.12441 PubMedPubMedCentralCrossRef

15.

Oberoi SS, Dhingra C, Sharma G, Sardana D (2015) Antibiotics in dental practice: how justified are we. Int Dent J 65(1):4–10. https://doi.org/10.1111/idj.12146 PubMedCrossRef

16.

Pittiruti M, Bertoglio S, Scoppettuolo G, Biffi R, Lamperti M, Dal Molin A, Panocchia N, Petrosillo N, Venditti M, Rigo C and DeLutio E (2016) Evidence-based criteria for the choice and the clinical use of the most appropriate lock solutions for central venous catheters (excluding dialysis catheters): a GAVeCeLT consensus. J Vasc Access 0(6):453–464. doi:https://doi.org/10.5301/jva.5000576

17.

Sherertz RJ, Boger MS, Collins CA, Mason L, Raad II (2006) Comparative in vitro efficacies of various catheter lock solutions. Antimicrob Agents Chemother 50(5):1865–1868. https://doi.org/10.1128/AAC.50.5.1865-1868.2006 PubMedPubMedCentralCrossRef

18.

Gidley MJ, Sanders JK, Myers ER, Allwood MC (1981) The mode of antibacterial action of some ‘masked’ formaldehyde compounds. FEBS Lett 127(2):225–227PubMedCrossRef

19.

Caruso F, Darnowski JW, Opazo C, Goldberg A, Kishore N, Agoston ES, Rossi M (2010) Taurolidine antiadhesive properties on interaction with E. coli; its transformation in biological environment and interaction with bacteria cell wall. PLoS One 5(1):e8927. https://doi.org/10.1371/journal.pone.0008927 PubMedPubMedCentralCrossRef

20.

Reynolds S, Moran J, Wade WG, Addy M, Newcombe R (1991) Taurolin as an oral rinse. II. Effects on in vitro and in vivo plaque regrowth. Clin Prev Dent 13(2):18–22PubMed

21.

Reynolds S, Moran J, Addy M, Wade WG, Newcombe R (1991) Taurolin as an oral rinse. I. Antimicrobial effects in vitro and in vivo. Clin Prev Dent 13(2):13–17PubMed

22.

Arweiler NB, Auschill TM, Sculean A (2012) Antibacterial effect of taurolidine (2%) on established dental plaque biofilm. Clin Oral Investig 16(2):499–504. https://doi.org/10.1007/s00784-011-0526-y PubMedCrossRef

23.

Eick S, Radakovic S, Pfister W, Nietzsche S, Sculean A (2012) Efficacy of taurolidine against periodontopathic species—an in vitro study. Clin Oral Investig 16(3):735–744. https://doi.org/10.1007/s00784-011-0567-2 PubMedCrossRef

24.

Zollinger L, Schnyder S, Nietzsche S, Sculean A, Eick S (2015) In-vitro activity of taurolidine on single species and a multispecies population associated with periodontitis. Anaerobe 32:18–23. https://doi.org/10.1016/j.anaerobe.2014.11.008 PubMedCrossRef

25.

Eick S, Gloor N, Puls C, Zumbrunn J, Sculean A (2016) In vitro activity of taurolidine gel on bacteria associated with periodontitis. Clin Oral Investig 20(3):597–606. https://doi.org/10.1007/s00784-015-1549-6 PubMedCrossRef

26.

Syed SA, Loesche WJ (1972) Survival of human dental plaque flora in various transport media. Appl Microbiol 24(4):638–644PubMedPubMedCentral

27.

Walker C, Sedlacek MJ (2007) An in vitro biofilm model of subgingival plaque. Oral Microbiol Immunol 22(3):152–161. https://doi.org/10.1111/j.1399-302X.2007.00336.x PubMedPubMedCentralCrossRef

28.

Eick S, Straube A, Guentsch A, Pfister W, Jentsch H (2011) Comparison of real-time polymerase chain reaction and DNA-strip technology in microbiological evaluation of periodontitis treatment. Diagn Microbiol Infect Dis 69(1):12–20. https://doi.org/10.1016/j.diagmicrobio.2010.08.017 PubMedCrossRef

29.

Kwasny SM, Opperman TJ (2010) Static biofilm cultures of Gram-positive pathogens grown in a microtiter format used for anti-biofilm drug discovery. Curr Protoc Pharmacol Chapter 13:Unit 13A 8. doi:https://doi.org/10.1002/0471141755.ph13a08s50

30.

Pettit RK, Weber CA, Kean MJ, Hoffmann H, Pettit GR, Tan R, Franks KS, Horton ML (2005) Microplate Alamar blue assay for Staphylococcus epidermidis biofilm susceptibility testing. Antimicrob Agents Chemother 49:2612–2617. https://doi.org/10.1128/AAC.49.7.2612-2617.2005 PubMedPubMedCentralCrossRef

31.

Beikler T, Schnitzer S, Abdeen G, Ehmke B, Eisenacher M, Flemmig TF (2006) Sampling strategy for intraoral detection of periodontal pathogens before and following periodontal therapy. J Periodontol 77(8):1323–1332. https://doi.org/10.1902/jop.2006.050204 PubMedCrossRef

32.

Ruhl S, Berlenbach P, Langenfelder S, Horl D, Lehn N, Hiller KA, Schmalz G, Durchschlag H (2011) Integrity of proteins in human saliva after sterilization by gamma irradiation. Appl Environ Microbiol 77(3):749–755. https://doi.org/10.1128/AEM.01374-10 PubMedCrossRef

33.

Sedlacek MJ, Walker C (2007) Antibiotic resistance in an in vitro subgingival biofilm model. Oral Microbiol Immunol 22(5):333–339. https://doi.org/10.1111/j.1399-302X.2007.00366.x PubMedPubMedCentralCrossRef

34.

Voos AC, Kranz S, Tonndorf-Martini S, Voelpel A, Sigusch H, Staudte H, Albrecht V, Sigusch BW (2014) Photodynamic antimicrobial effect of safranine O on an ex vivo periodontal biofilm. Lasers Surg Med 46(3):235–243. https://doi.org/10.1002/lsm.22217 PubMedCrossRef

35.

Latimer J, Munday JL, Buzza KM, Forbes S, Sreenivasan PK, McBain AJ (2015) Antibacterial and anti-biofilm activity of mouthrinses containing cetylpyridinium chloride and sodium fluoride. BMC Microbiol 15(1):169. https://doi.org/10.1186/s12866-015-0501-x PubMedPubMedCentralCrossRef

36.

Sculean A, Auschill TM, Donos N, Brecx M, Arweiler NB (2001) Effect of an enamel matrix protein derivative (Emdogain) on ex vivo dental plaque vitality. J Clin Periodontol 28(11):1074–1078. https://doi.org/10.1034/j.1600-051X.2001.281113.x PubMedCrossRef

37.

Sreenivasan PK, Haraszthy VI, Zambon JJ (2013) Antimicrobial efficacy of 0.05% cetylpyridinium chloride mouthrinses. Lett Appl Microbiol 56(1):14–20. https://doi.org/10.1111/lam.12008 PubMedCrossRef

38.

Goodson JM (2003) Gingival crevice fluid flow. Periodontol 31(1):43–54. https://doi.org/10.1034/j.1600-0757.2003.03104.x CrossRef

39.

Flemming HC, Wingender J, Szewzyk U, Steinberg P, Rice SA, Kjelleberg S (2016) Biofilms: an emergent form of bacterial life. Nat Rev Microbiol 14(9):563–575. https://doi.org/10.1038/nrmicro.2016.94 PubMedCrossRef

40.

Ribeiro SM, Felicio MR, Boas EV, Goncalves S, Costa FF, Samy RP, Santos NC, Franco OL (2016) New frontiers for anti-biofilm drug development. Pharmacol Ther 160:133–144. https://doi.org/10.1016/j.pharmthera.2016.02.006 PubMedCrossRef

41.

Quintas V, Prada-Lopez I, Donos N, Suarez-Quintanilla D, Tomas I (2015) In situ neutralisation of the antibacterial effect of 0.2% chlorhexidine on salivary microbiota: quantification of substantivity. Arch Oral Biol 60(8):1109–1116. https://doi.org/10.1016/j.archoralbio.2015.04.002 PubMedCrossRef

42.

Olthof ED, Rentenaar RJ, Rijs AJ, Wanten GJ (2013) Absence of microbial adaptation to taurolidine in patients on home parenteral nutrition who develop catheter related bloodstream infections and use taurolidine locks. Clin Nutr 32(4):538–542. https://doi.org/10.1016/j.clnu.2012.11.014 PubMedCrossRef

43.

Hartel C, Scholz T, Kuhn M, Bendiks M, Gopel W, Lauten M, Herting E (2013) Innate immune responses to Stenotrophomonas maltophilia in immunocompromised pediatric patients and the effect of taurolidine. J Microbiol Immunol Infect 46(2):115–120. https://doi.org/10.1016/j.jmii.2012.04.002 PubMedCrossRef

44.

Chromik AM, Muller AM, Albrecht M, Rottmann S, Otte JM, Herdegen T, Uhl W, Mittelkotter U (2007) Oral administration of taurolidine ameliorates chronic DSS colitis in mice. J Investig Surg 20(5):273–282. https://doi.org/10.1080/08941930701598784 CrossRef

45.

Rohner E, Kolar P, Seeger JB, Arnholdt J, Thiele K, Perka C, Matziolis G (2011) Toxicity of antiseptics against chondrocytes: what is best for the cartilage in septic joint surgery? Int Orthop 35(11):1719–1723. https://doi.org/10.1007/s00264-010-1178-2 PubMedPubMedCentralCrossRef

46.

Ulusoy AT, Kalyoncuoglu E, Reis A, Cehreli ZC (2016) Antibacterial effect of N-acetylcysteine and taurolidine on planktonic and biofilm forms of Enterococcus faecalis. Dent Traumatol 32(3):212–218. https://doi.org/10.1111/edt.12237 PubMedCrossRef

47.

John G, Schwarz F, Becker J (2015) Taurolidine as an effective and biocompatible additive for plaque-removing techniques on implant surfaces. Clin Oral Investig 19(5):1069–1077. https://doi.org/10.1007/s00784-014-1337-8 PubMedCrossRef

48.

Umeda M, Takeuchi Y, Noguchi K, Huang Y, Koshy G, Ishikawa I (2004) Effects of nonsurgical periodontal therapy on the microbiota. Periodontol 2000(36):98–120. https://doi.org/10.1111/j.1600-0757.2004.03675.x CrossRef

49.

Bonito AJ, Lux L, Lohr KN (2005) Impact of local adjuncts to scaling and root planing in periodontal disease therapy: a systematic review. J Periodontol 76(8):1227–1236. https://doi.org/10.1902/jop.2005.76.8.1227 PubMedCrossRef

50.

Drisko CL (2014) Periodontal debridement: still the treatment of choice. J Evid Based Dent Pract 14(Suppl):33–41 e1. https://doi.org/10.1016/j.jebdp.2014.02.007 PubMedCrossRef

Titel: Activity of taurolidine gels on ex vivo periodontal biofilm
verfasst von: Luca Pirracchio
Aline Joos
Nina Luder
Anton Sculean
Sigrun Eick
Publikationsdatum: 14.12.2017
Verlag: Springer Berlin Heidelberg
Erschienen in: Clinical Oral Investigations / Ausgabe 5/2018
Print ISSN: 1432-6981
Elektronische ISSN: 1436-3771
DOI: https://doi.org/10.1007/s00784-017-2297-6

Neu im Fachgebiet Zahnmedizin

Parodontalbehandlung verbessert Prognose bei Katheterablation

19.04.2024 Vorhofflimmern Nachrichten

Werden Personen mit Vorhofflimmern in der Blanking-Periode nach einer Katheterablation gegen eine bestehende Parodontitis behandelt, verbessert dies die Erfolgsaussichten. Dafür sprechen die Resultate einer prospektiven Untersuchung.

Invasive Zahnbehandlung: Wann eine Antibiotikaprophylaxe vor infektiöser Endokarditis schützt

11.04.2024 Endokarditis Nachrichten

Bei welchen Personen eine Antibiotikaprophylaxe zur Prävention einer infektiösen Endokarditis nach invasiven zahnärztlichen Eingriffen sinnvoll ist, wird diskutiert. Neue Daten stehen im Einklang mit den europäischen Leitlinienempfehlungen.

Zell-Organisatoren unter Druck: Mechanismen des embryonalen Zahnwachstums aufgedeckt

08.04.2024 Zahnmedizin Nachrichten

Der Aufbau von Geweben und Organen während der Embryonalentwicklung wird von den Zellen bemerkenswert choreografiert. Für diesen Prozess braucht es spezielle sogenannte „Organisatoren“. In einer aktuellen Veröffentlichung im Fachjournal Nature Cell Biology berichten Forschende durch welchen Vorgang diese Organisatoren im Gewebe entstehen und wie sie dann die Bildung von Zähnen orchestrieren.

Die Oralprophylaxe & Kinderzahnheilkunde umbenannt

11.03.2024 Kinderzahnmedizin Nachrichten

Infolge der Umbenennung der Deutschen Gesellschaft für Kinderzahnheilkunde in Deutsche Gesellschaft für Kinderzahnmedizin (DGKiZ) wird deren Mitgliederzeitschrift Oralprophylaxe & Kinderzahnheilkunde in Oralprophylaxe & Kinderzahnmedizin umbenannt. Aus diesem Grunde trägt die erste Ausgabe in 2024 erstmalig den neuen Titel.

Bestellen Sie unseren kostenlosen Newsletter Update Zahnmedizin und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen

Springer Medizin

Abstract

Objectives

Material and methods

Results

Conclusion

Clinical relevance

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2018

Micro-CT evaluation of voids using two root filling techniques in the placement of MTA in mesial root canals of Vertucci type II configuration

Cost assessment of a new oral care program in the intensive care unit to prevent ventilator-associated pneumonia

The effectiveness of two types of MADS for OSA therapy

Bisphosphonates hinder osteoblastic/osteoclastic differentiation in the maxillary sinus mucosa-derived stem cells

Bond strength of adhesive systems to sound and demineralized dentin treated with bioactive glass ceramic suspension

Conservative surgical treatments for nonsyndromic odontogenic keratocysts: a systematic review and meta-analysis

Neu im Fachgebiet Zahnmedizin

Parodontalbehandlung verbessert Prognose bei Katheterablation

Invasive Zahnbehandlung: Wann eine Antibiotikaprophylaxe vor infektiöser Endokarditis schützt

Zell-Organisatoren unter Druck: Mechanismen des embryonalen Zahnwachstums aufgedeckt

Die Oralprophylaxe & Kinderzahnheilkunde umbenannt

Newsletter